• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Stem Cells

HighQC™ Human IPSC From Fibroblast-Congenital Disorder Of Deglycosylation

  • For research use only

Cat No.

ABC-SC2064

Product Type

Human iPSCs

Cell Type

Induced Pluripotent Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Congenital Disorder Of Deglycosylation

Storage

Liquid Nitrogen

Employ HighQC™ Human IPSC From Fibroblast-Congenital Disorder Of Deglycosylation for rare genetic disease modeling, drug testing, and molecular studies.

Product Image

Description

HighQC™ Human IPSC From Fibroblast-Congenital Disorder of Deglycosylation is a disease-specific human induced pluripotent stem cell line derived from dermal fibroblasts of a donor diagnosed with a Congenital Disorder of Deglycosylation (CDDG), a group of rare inherited metabolic diseases characterized by defects in glycoprotein synthesis. The resulting iPSCs (induced pluripotent stem cells) exhibit adherent growth with a high nucleus-to-cytoplasm ratio. They maintain pluripotency and model CDDG-related glycosylation traits. These cells retain the fundamental capacity for trilineage differentiation into cell types of the ectoderm, mesoderm, and endoderm germ layers. They express the core pluripotency marker SSEA-4. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.

Product Code

HighQC™ Human IPSC From Fibroblast-Congenital Disorder Of Deglycosylation, HighQC™ hiPSC CDG, hiPSC-CDG, HighQC™ Human Induced Pluripotent Stem Cells From Fibroblast-Congenital Disorder Of Deglycosylation

Species

Human

Cat.No

ABC-SC2064

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Induced Pluripotent Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Fibroblast

Disease

Congenital Disorder Of Deglycosylation

Storage

Liquid Nitrogen

Product Type

Human iPSCs

Gene Info

CACNA1S NGLY1

Application

  • HighQC™ Human IPSC From Fibroblast-Congenital Disorder of Deglycosylation provides a patient-specific model for in vitro studies of glycoprotein metabolism and disease pathogenesis. Its pluripotent capacity enables directed differentiation into diverse lineages such as hepatocytes, cardiomyocytes, and neuronal cells to investigate the cellular and tissue-specific consequences of glycosylation defects. This system is used to model disease mechanisms, study early developmental pathways affected by protein glycosylation, and serve as a platform for compound screening to identify potential therapeutic agents targeting this metabolic disorder.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human IPSC From Fibroblast-Congenital Disorder Of Deglycosylation

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button